Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Di Leo

Showing results (51-60 of 187) with videos related to

Pageof 19
Sort By:
Breast (Edinburgh, Scotland)|July 6, 2017
De-escalating and escalating treatment beyond endocrine therapy in patients with luminal breast cancerAmelia McCartney, Alessia Vignoli, Christopher Hart, et al.
Cancer Treatment Reviews|May 19, 2018
Metabolomics in breast cancer: A decade in reviewAmelia McCartney, Alessia Vignoli, Laura Biganzoli, et al.
Pharmacological Research|February 28, 2016
Using CTCs for pharmacogenomic analysisChristopher D Hart, Francesca Galardi, Marta Pestrin, et al.
Breast (Edinburgh, Scotland)|October 22, 2011
Adjuvant systemic treatment for individual patients with triple negative breast cancerCatherine Oakman, Erica Moretti, Francesca Galardi, et al.
Breast (Edinburgh, Scotland)|November 17, 2009
Adjuvant chemotherapy--the dark side of clinical trials. Have we learnt more?Catherine Oakman, Marta Pestrin, Egidia Cantisani, et al.
Critical Reviews in Oncology/Hematology|March 21, 2012
Metabolomics in cancer: a bench-to-bedside intersectionWederson M Claudino, Priscila H Goncalves, Angelo di Leo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Prognostic and predictive value of HER2 extracellular domain in metastatic breast cancer treated with lapatinib and paclitaxel in a randomized phase III studyRichard S Finn, Robert Gagnon, Angelo Di Leo, et al.
The International Journal of Biochemistry & Cell Biology|May 13, 2010
Uncovering the metabolomic fingerprint of breast cancerCatherine Oakman, Leonardo Tenori, Laura Biganzoli, et al.
Cancer Treatment Reviews|January 11, 2015
A new era of improving progression-free survival with dual blockade in postmenopausal HR(+), HER2(-) advanced breast cancerGuy Jerusalem, Thomas Bachelot, Carlos Barrios, et al.
The EPMA Journal|September 3, 2015
Discovery of novel mutations in the dihydropyrimidine dehydrogenase gene associated with toxicity of fluoropyrimidines and viewpoint on preemptive pharmacogenetic screening in patientsMarzia Del Re, Angela Michelucci, Angelo Di Leo, et al.
Pageof 19

Showing results (51-60 of 187) with videos related to

Sort By:
Pageof 19
Breast (Edinburgh, Scotland)|July 6, 2017
De-escalating and escalating treatment beyond endocrine therapy in patients with luminal breast cancerAmelia McCartney, Alessia Vignoli, Christopher Hart, et al.
Cancer Treatment Reviews|May 19, 2018
Metabolomics in breast cancer: A decade in reviewAmelia McCartney, Alessia Vignoli, Laura Biganzoli, et al.
Pharmacological Research|February 28, 2016
Using CTCs for pharmacogenomic analysisChristopher D Hart, Francesca Galardi, Marta Pestrin, et al.
Breast (Edinburgh, Scotland)|October 22, 2011
Adjuvant systemic treatment for individual patients with triple negative breast cancerCatherine Oakman, Erica Moretti, Francesca Galardi, et al.
Breast (Edinburgh, Scotland)|November 17, 2009
Adjuvant chemotherapy--the dark side of clinical trials. Have we learnt more?Catherine Oakman, Marta Pestrin, Egidia Cantisani, et al.
Critical Reviews in Oncology/Hematology|March 21, 2012
Metabolomics in cancer: a bench-to-bedside intersectionWederson M Claudino, Priscila H Goncalves, Angelo di Leo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Prognostic and predictive value of HER2 extracellular domain in metastatic breast cancer treated with lapatinib and paclitaxel in a randomized phase III studyRichard S Finn, Robert Gagnon, Angelo Di Leo, et al.
The International Journal of Biochemistry & Cell Biology|May 13, 2010
Uncovering the metabolomic fingerprint of breast cancerCatherine Oakman, Leonardo Tenori, Laura Biganzoli, et al.
Cancer Treatment Reviews|January 11, 2015
A new era of improving progression-free survival with dual blockade in postmenopausal HR(+), HER2(-) advanced breast cancerGuy Jerusalem, Thomas Bachelot, Carlos Barrios, et al.
The EPMA Journal|September 3, 2015
Discovery of novel mutations in the dihydropyrimidine dehydrogenase gene associated with toxicity of fluoropyrimidines and viewpoint on preemptive pharmacogenetic screening in patientsMarzia Del Re, Angela Michelucci, Angelo Di Leo, et al.
Pageof 19